Clinical trial
Topical Antiperspirant for Hand-Foot Syndrome
NCT00213993 · University of Wisconsin, Madison, Other · Completed
Key facts
| NCT number | NCT00213993 |
|---|---|
| Title | Topical Antiperspirant for Hand-Foot Syndrome |
| Official title | Topical Antiperspirant for Prevention of Palmar-Plantar Erythrodysesthesia (Hand-Foot Syndrome) Associated With Capecitabine |
| Lead sponsor | University of Wisconsin, Madison, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Palmar-plantar Erythrodysesthesia |
| Intervention type | Drug |
| Interventions | antiperspirant |
| Enrollment | 14 |
| Start date | May 1, 2005 |
| Primary completion | Oct 1, 2006 |
| Completion | Jan 1, 2007 |
| First posted | Sep 21, 2005 |
| Last update posted | Oct 5, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: